Skip to main content
. 2020 May 1;115(8):1217–1225. doi: 10.14309/ajg.0000000000000605

Figure 2.

Figure 2.

Viral suppression by study visit. (a) Proportions of patients with HBV DNA <69 IU/mL as determined by the FAS. (b) Proportions of patients with HBV DNA <20 IU/mL as determined by FAS. Bars represent 95% confidence intervals. BSV, besifovir dipivoxil maleate; FAS, full analysis set; HBV, hepatitis B virus; TDF, tenofovir disoproxil fumarate.